Performance of SN Smith & Nephew PLC | -21.2% in 12m
Compare SN with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Smith & Nephew PLC with its related Sector/Index XLV
Performance Duell SN vs XLV
TimeFrame | SN | XLV |
---|---|---|
1 Day | 0.92% | -0.07% |
1 Week | 2.20% | 0.40% |
1 Month | 1.17% | -2.57% |
3 Months | -8.12% | -0.71% |
6 Months | 4.77% | 11.70% |
12 Months | -21.2% | 6.84% |
YTD | -5.58% | 1.59% |
Rel. Perf. 1m | 0.30 | |
Rel. Perf. 3m | -1.10 | |
Rel. Perf. 6m | -0.23 | |
Rel. Perf. 12m | -3.02 |
Is Smith & Nephew PLC a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Smith & Nephew PLC (LSE:SN) is currently (May 2024)
ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 36.54 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SN as of May 2024 is 852.25. This means that SN is currently overvalued and has a potential downside of -13.53% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SN as of May 2024 is 852.25. This means that SN is currently overvalued and has a potential downside of -13.53% (Sold with Premium).
Is SN a buy, sell or hold?
Smith & Nephew PLC has no consensus analysts rating. ValueRay therefore judges the recommendation based on the last 12 Month Returns of -21.18%.
In compare to Health Care Sector SPDR Fund, SN made -28.02% less over the last 12 months. Due to the underperformance, it is recommend to sell SN.
In compare to Health Care Sector SPDR Fund, SN made -28.02% less over the last 12 months. Due to the underperformance, it is recommend to sell SN.
Values above 0%: SN is performing better - Values below 0%: SN is underperforming
Compare SN with Broad Market Indices
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 1.89% | 3.83% | -13.31% | -45.89% |
US NASDAQ 100 | QQQ | 1.62% | 4.39% | -13.14% | -55.74% |
US Dow Jones Industrial 30 | DIA | 1.86% | 3.52% | -9.24% | -36.84% |
German DAX 40 | DBXD | 2.39% | 3.45% | -13.08% | -34.32% |
UK FTSE 100 | ISFU | 0.92% | -1.55% | -9.78% | -30.73% |
Shanghai Shenzhen CSI 300 | CSI 300 | -2.73% | -2.18% | 0.14% | -11.23% |
Hongkong Hang Seng | HSI | -4.67% | -5.03% | 4.27% | -6.71% |
Japan Nikkei 225 | EXX7 | -0.16% | 6.53% | -9.10% | -40.98% |
India NIFTY 50 | INDA | 0.88% | -1.56% | -16.11% | -50.46% |
Brasil Bovespa | EWZ | -0.95% | 1.89% | 0.44% | -44.56% |
SN Smith & Nephew PLC vs. Sectors
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 0.39% | 4.57% | -15.13% | -57.47% |
Consumer Discretionary | XLY | 0.83% | 2.90% | -7.52% | -42.70% |
Consumer Staples | XLP | 2.33% | 0.79% | -7.05% | -21.92% |
Energy | XLE | 6.41% | 5.19% | -2.82% | -40.12% |
Financial | XLF | 3.23% | 4.07% | -17.64% | -48.56% |
Health Care | XLV | 1.80% | 3.74% | -6.93% | -28.02% |
Industrial | XLI | 2.64% | 3.17% | -17.33% | -45.78% |
Materials | XLB | 2.58% | 5.18% | -10.70% | -34.63% |
Real Estate | XLRE | 1.38% | 5.54% | -4.19% | -24.66% |
Technology | XLK | 2.47% | 5.90% | -11.59% | -54.06% |
Utilities | XLU | 0.78% | -2.67% | -7.55% | -24.03% |
Aerospace & Defense | XAR | -0.63% | 0.15% | -10.98% | -42.26% |
Biotech | XBI | -5.24% | 3.75% | -24.67% | -32.00% |
Homebuilder | XHB | 1.17% | 5.18% | -32.99% | -69.68% |
Retail | XRT | 1.81% | 6.10% | -16.18% | -42.19% |
Does Smith & Nephew PLC outperform its market, is SN a Sector Leader?
No, over the last 12 months Smith & Nephew PLC (SN) made -21.18%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 6.84%.
Over the last 3 months SN made -8.12%, while XLV made -0.71%.
No, over the last 12 months Smith & Nephew PLC (SN) made -21.18%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 6.84%.
Over the last 3 months SN made -8.12%, while XLV made -0.71%.
Period | SN | XLV | S&P 500 |
---|---|---|---|
1 Month | 1.17% | -2.57% | -2.66% |
3 Months | -8.12% | -0.71% | 2.48% |
12 Months | -21.18% | 6.84% | 24.71% |